Mitochondrial DNA Haplogroups and Susceptibility to Neuroblastoma
Open Access
- 25 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 112 (12), 1259-1266
- https://doi.org/10.1093/jnci/djaa024
Abstract
Neuroblastoma is a childhood malignancy that arises from the developing sympathetic nervous system. Although mitochondrial dysfunctions have been implicated in the pathophysiology of neuroblastoma, the role of mitochondrial DNA (mtDNA) has not been extensively investigated. A total of 2404 Caucasian children diagnosed with neuroblastoma and 9310 ancestry-matched controls were recruited at the Children’s Hospital of Philadelphia. The mtDNA haplogroups were identified from SNP array data of two independent cohorts. We conducted a case-control study to explore potential associations of mtDNA haplogroups with the susceptibility of neuroblastoma. The genetic effect of neuroblastoma was measured by odds ratios (ORs) of mitochondrial haplogroups. All tests were two-sided. Haplogroup K was statistically significantly associated with reduced risk of neuroblastoma in the discovery cohort consisting of 1474 cases and 5699 controls (OR = 0.72, 95% confidence interval [CI] = 0.57 to 0.90; P = 4.8 × 10-3). The association was replicated in an independent cohort (OR = 0.69, 95% CI = 0.53 to 0.92; P = .01) of 930 cases and 3611 controls. Pooled analysis was performed by combining the two data sets. The association remained highly statistically significant after correction for multiple testing (OR = 0.71, 95% CI = 0.59 to 0.84, P = 1.96 × 10-4, Pcorrected = .002). Further analysis focusing on neuroblastoma subtypes indicated haplogroup K was more associated with high-risk neuroblastoma (OR = 0.57, 95% CI = 0.43 to 0.76; P = 1.46 × 10–4) than low-risk and intermediate-risk neuroblastoma. Haplogroup K is an independent genetic factor associated with reduced risk of developing neuroblastoma in European descents. These findings provide new insights into the genetic basis of neuroblastoma, implicating mitochondrial DNA encoded proteins in the etiology of neuroblastoma.Funding Information
- Institutional Development Funds from the Children’s Hospital of Philadelphia
- NIH (U01HG006830, R01CA124709, R01CA180692, R35CA220500)
This publication has 50 references indexed in Scilit:
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaNature Genetics, 2012
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohortNeurobiology of Aging, 2010
- Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association studyThe Lancet Neurology, 2010
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- Common genetic variants on 5p14.1 associate with autism spectrum disordersNature, 2009
- Mitochondrial DNA Polymorphism and Risk of CancerMethods in molecular biology (Clifton, N.J.), 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Chromosome 6p22 Locus Associated with Clinically Aggressive NeuroblastomaThe New England Journal of Medicine, 2008
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006